E1 Lecture 4: Liposomes & Nanotechnology

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/25

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

26 Terms

1
New cards

What are the 5 methods of Liposome/ Nanotechnology drug delivery?

-Injection
-Oral Delivery
-Inhalation
-Implantation
-Transdermal

2
New cards

What are current problems in drug delivery of Liposomes and Nanotechnology

-Poor bioavailability
-High initial release (burst)
-Loss of bioactivity
-Delivery to non-targeted sites

3
New cards

Define nanomedicine

Application of nanotechnology to diagnosis and treatment of diseases

4
New cards

What are Research Medical Applications of Nanotechnology

-Drug Screening (labeling)
-Gene Delivery (Transfection)
-Diagnosis (devices and labeling)

5
New cards

What are Clinical Medical applications of Nanotechnology

-Drug delivery (therapy)
-Detection (imaging)
-Diagnosis/ Monitoring (Disease Markers)

6
New cards

What is nanoscience

Study of objects measured in nanometers

7
New cards

What are advantages of nano-medicine

-Protects drugs from being degraded before reaching target
-Enhances absorption of drugs into tumors and cancerous cells
-Between control of timing and distribution
-Prevent drugs from interacting with normal cells, avoiding side effects

8
New cards

What is the MOA of nano-encapsulation for drug delivery

- Can allow encapsulation of hydrophobic drugs which are difficult to get into your mostly water body
-Encapsulation of drugs that are easily destroyed in blood stream

9
New cards

What is the goal for targeted delivery to tumors using Nanotechnology

Inject treatment far from tumor and have large accumulation in the tumor and minimal accumulation in normal cells

10
New cards

What are disadvantages of Nano-medicine

-Expensive
-Difficult to manufacture
-Drug leakage
-Reticuloendothelial systems endocytosis
-Reproducibility
-Stability

11
New cards

What is a liposome

A self closing spherical partical with a lipid bilayer

12
New cards

Define amphiphilic

Can entrap water-soluble and water-insoluble drugs

13
New cards

The following are examples of _____________
- Doxil
-AmBisome
DepoCyt
-Marqibo
- Abraxane

Liposomes

14
New cards

Doxil is a liposomal injection that is used as a

Chemotherapy agent

15
New cards

How does STEALTH technology help DOXIL work?

Helps to evade detection and destruction of immune system, allowing more time to reach tumor

16
New cards

Ambisome is a lisosomal medication used for

Antifungal infections

17
New cards

Depo-Cyt is a lysosomal medication used for

Meningitis

18
New cards

Abraxane is a lysosomal medication used for

Chemotherapy for breast cancer

19
New cards

The concept of "clever" drug targeting system includes the coordinating behavior of which three components

Targeting moiety, the carrier, and therapeutic drugs

20
New cards

What is the job of the targeting moiety in a smart lysosome DDS

Recognize and bind to target

21
New cards

What is the function of the carrier in a smart lysosome DDS

Carries the drug

22
New cards

What is the function of the therapeutic drug in a lysosomal DDS

Provide therapeutic action to site

23
New cards

The following are examples of


-Antibodies
-Proteins
-Lipoproteins
-Hormones
-Charged Molecules
-Polysaacharides
-Low-MW ligands

Targeting Moieties

24
New cards

What are the 5 types of Polymeric nanoparticles

-Polymeric Drug/Sequestrant
-Polymer-Protein Conjugate
-Polyplex: Polymer DNA complex
-Polymer-Drug conjugate
-Polymeric Micelle

<p>-Polymeric Drug/Sequestrant <br>-Polymer-Protein Conjugate<br>-Polyplex: Polymer DNA complex <br>-Polymer-Drug conjugate<br>-Polymeric Micelle</p>
25
New cards

Can polymers act as an active ingredient? If so, give an example

Yes. Copaxone

26
New cards

What is a drug pegasys

Conjugated polymer nanoparticle used for Hepatitis B & C. Has a PEG chain that enhances plasma stability and solubity of the drug while reducing immunogenicity